Variable reduction of caveolin-3 in patients with LGMD2B/MM

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Maggie C. Walter - , Ludwig Maximilian University of Munich (Author)
  • Christian Braun - , Ludwig Maximilian University of Munich (Author)
  • Matthias Vorgerd - , Ruhr University Bochum (Author)
  • Maja Poppe - , TUD Dresden University of Technology (Author)
  • Christian Thirion - , Ludwig Maximilian University of Munich (Author)
  • Carolin Schmidt - , Ludwig Maximilian University of Munich (Author)
  • Herbert Schreiber - , Ulm University (Author)
  • Ursula I. Knirsch - , Ulm University (Author)
  • Dagmar Brummer - , Ulm University (Author)
  • Wolfgang Müller-Felber - , Ludwig Maximilian University of Munich (Author)
  • Dieter Pongratz - , Ludwig Maximilian University of Munich (Author)
  • Josef Müller-Höcker - , Ludwig Maximilian University of Munich (Author)
  • Angela Huebner - , Department of Paediatrics, Department of Child and Adolescent Psychiatry and Psychotherapy , TUD Dresden University of Technology (Author)
  • Hanns Lochmüller - , Ludwig Maximilian University of Munich (Author)

Abstract

Mutations in the human dysferlin gene (DYSF) cause autosomal recessive muscular dystrophies characterized by degeneration and weakness of proximal and/or distal muscles: limb girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi myopathy (MM). Recently, an interaction between caveolin-3 and dysferlin in normal and dystrophic muscle (primary caveolin-3 deficiency; LGMD1C) was shown. In this study, clinical, morphological and genetic analysis was carried out in four independent LGMD2B/MM patients. All patients presented with an adult-onset, slowly progressive muscular dystrophy with variable involvement of proximal and distal muscles. We found complete lack of dysferlin in the four LGMD2B/MM patients. Secondary reduction of caveolin-3 was detected in three out of the four patients. Regular caveolae were detected along the basal lamina in two patients by electron microscopy. We provide further evidence that dysferlin and caveolin-3 interact in human skeletal muscle. It remains to be elucidated whether the loss of this interaction contributes to pathogenic events in muscular dystrophy.

Details

Original languageEnglish
Pages (from-to)1431-1438
Number of pages8
JournalJournal of neurology
Volume250
Issue number12
Publication statusPublished - Dec 2003
Peer-reviewedYes

External IDs

PubMed 14673575

Keywords

ASJC Scopus subject areas

Keywords

  • Caveolin-3, Dysferlin, LGMD2B, Miyoshi myopathy, Muscular dystrophy